Related Experiment Videos
Soy isoflavones: are they useful in menopause?
1Division of Endocrinology, Metabolism, Nutrition and Internal Medicine, Mayo Clinic, Rochester, Minn 55905, USA.
Mayo Clinic Proceedings
|November 15, 2000
Summary
Soy protein intake, particularly 25 g daily, can significantly lower cholesterol and LDL levels. While soy isoflavones show potential benefits for breast health, more research is needed for osteoporosis and hormone replacement therapy.
Area of Science:
- Nutritional Science
- Endocrinology
- Cardiovascular Health
Background:
- Soy protein and isoflavones are recognized for potential health benefits.
- Health claims for soy protein and reduced risk of coronary heart disease are authorized by the FDA.
- Soy isoflavones are phytoestrogens with structural similarities to estradiol.
Purpose of the Study:
- To evaluate the effects of soy protein and isoflavones on cardiovascular health markers.
- To explore the potential benefits of soy isoflavones on breast tissue, bone health, and menopausal symptoms.
- To assess the safety profile of soy protein and isoflavones in humans.
Main Methods:
- Review of epidemiological studies and clinical trials on soy consumption.
- Analysis of data on serum lipid concentrations, including total cholesterol, LDL cholesterol, HDL cholesterol, and triglycerides.
- Examination of studies investigating the effects of soy on breast cancer rates, osteoporosis, endometrium, hot flashes, and cognition.
Main Results:
- Daily intake of 25 g soy protein with a low-fat diet significantly reduces total cholesterol and LDL cholesterol.
- Soy consumption decreases total cholesterol, LDL cholesterol, and triglycerides but does not affect HDL cholesterol.
- Epidemiological data suggest a protective effect of soy on breast tissue; effects on osteoporosis, endometrium, cognition, and hot flashes require further investigation.
Conclusions:
- Soy protein effectively lowers cardiovascular risk factors like cholesterol.
- Soy isoflavones exhibit potential tissue-specific effects, but conclusive evidence for hormone replacement therapy is lacking.
- While generally safe in humans, further randomized controlled trials are necessary to confirm benefits and establish definitive roles for soy isoflavones.